Compare Aehr Test Systems (AEHR) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aehr Test Systems vs Novartis AG — how do they compare? Aehr Test Systems trades at $122 (market cap $3.82B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 77.3× Aehr Test Systems's market cap, and Novartis AG pays a 3.07% dividend while Aehr Test Systems pays none. Which is the better fit depends on your goals.
| AEHR | NVS | |
|---|---|---|
Market Cap | $3.82B | $295.37B |
Sector | Technology | Health |
52-Week High | $117.18 | $168.62 |
52-Week Low | $17.38 | $119.31 |
Enterprise Value | $3.72B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aehr Test Systems
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
